Biopharma

STAT+: Medicare Advantage enrollment growth slows drast...

Enrollment in private Medicare Advantage plans grew just 3.1%, below projections...

Wearable defibrillator maker Kestra Medical plots $150M...

Kestra's vest-like Assure cardioverter defibrillators have been worn by more tha...

Merck expects oncology king Keytruda to face IRA 'price...

The government price negotiations affecting Keytruda wouldn't take effect until ...

Texas measles outbreak marks first fatality as more cas...

A child in Texas has died from measles, the AP reported, the first death from me...

AstraZeneca’s next breast cancer drug; Madrigal’s accel...

The British drugmaker claimed study success in a first-line setting in breast ca...

Jazz 'active and looking' at M&A deals of 'various size...

Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-qu...

FDA dings Piramal API plant with Form 483 detailing pro...

Following an inspection of Piramal’s production facility in Maharashtra, India, ...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, ...

STAT+: A bill is reintroduced in Congress to revise pro...

The bill would allow Medicare to begin negotiating with pharmaceutical companies...

Alopexx seeks $11M IPO to advance ex-Sanofi infectious ...

Alopexx is forging ahead with long-gestating plans to go public, updating IPO pa...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab,...

Certificates Processing System: Demo & Q&A session for ...

Certificates Processing System: Demo & Q&A session for industry stakeholders, On...

Annex - National provisions for SMEs applicable to the ...

Annex - National provisions for SMEs applicable to the pharmaceutical sector

Fierce Biotech Fundraising Tracker '25: Eikon's eye-cat...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

STAT+: Are we adopting AI scribes based on… vibes?

The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guid...

Eikon remains in megaround mode with $350M series D to ...

Eikon Therapeutics is no stranger to eye-catching funding rounds, and the cancer...

With $27B plan to build 4 new plants, Eli Lilly doubles...

At a press conference in Washington, D.C. dubbed “Lilly in America,” the Indiana...

Eli Lilly unveils $27bn US investment as corporate Amer...

Pharmaceutical industry is hoping to ward off growing tariff threat

STAT+: Eli Lilly announces $27 billion investment in U....

Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in th...

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as Presiden...

With plan to build 4 new plants, Eli Lilly doubles down...

At a press conference in Washington, D.C. dubbed “Lilly in America,” the Indiana...

STAT+: Pharmalittle: We’ve reading about abortion pill ...

GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading int...

Roger Perlmutter startup raises $350 million

The biotech news stories you need to read, brought to you by The Readout.

Third recipient of pig kidney heads home from hospital

Plus more health news stories to stay on top of this morning.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.